Big Moving Stocks for Nov-27 At The Close

These stocks are posting some big moves for today.

eFuture Information Technology Inc. (EFUT) < (EFUT) is currently trading at $15.89 + 7.74 (94.97%) on 4,134,747 shares traded. eFuture Information Technology Inc. (EFUT) < is +273.87% year-to-date, and +275.64% over the last 12 months.

EFuture Information Technology Inc develops & sells ERP software & provides ONE-STOP solutions for distribution, retail & logistics businesses focused on the supply chain front market for manufacturers, retailers, distributors & third party logistics.

Repros Therapeutics Inc. (RPRX) < (RPRX) is currently trading at $2.54 + 0.79 (45.14%) on 7,532,046 shares traded. Repros Therapeutics Inc. (RPRX) < is -74.52% year-to-date, and -71.84% over the last 12 months.

Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.

Kalobios Pharmaceuticals Inc (KBIO) < (KBIO) is currently trading at $34.83 + 8.20 (30.79%) on 4,341,287 shares traded. Kalobios Pharmaceuticals Inc (KBIO) < is +151.66% year-to-date, and +136.62% over the last 12 months.

KaloBios Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development of monoclonal antibody therapeutics for diseases that burdens the society and to patients and their families.

Macrocure Ltd. (MCUR) < (MCUR) is currently trading at $2.44 + 0.50 (25.77%) on 6,995,887 shares traded. Macrocure Ltd. (MCUR) < is -66.58% year-to-date, and -68.27% over the last 12 months.

Macrocure Ltd is a biotechnology company. The Company is engaged in developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds.

Harvard Apparatus Regenerative Technology Inc. (HART) < (HART) is currently trading at $2.20 + 0.445 (25.36%) on 2,972,986 shares traded. Harvard Apparatus Regenerative Technology Inc. (HART) < is -30.82% year-to-date, and -39.23% over the last 12 months.

Harvard Apparatus Regenerative Technology Inc is a clinical stage biotechnology company. The Company is engaged in the development and commercialization of regenerated organs for human transplant.

Highpower International Inc (HPJ) < (HPJ) is currently trading at $2.88 + 0.54 (23.08%) on 710,403 shares traded. Highpower International Inc (HPJ) < is -42.05% year-to-date, and -48.94% over the last 12 months.

Highpower International Inc and its subsidiaries manufacture and trades nickel metal hydride rechargeable batteries for both consumer and industrial applications.

ModSys International Ltd. (MDSY) < (MDSY) is currently trading at $2.01 + 0.30 (17.54%) on 3,100 shares traded. ModSys International Ltd. (MDSY) < is -41.91% year-to-date, and -41.91% over the last 12 months.

ModSys International Ltd through its subsidiary is engaged in providing legacy modernization solutions. It offers customers a platform of automated tools, services, and domain expertise from automated database, language and application migration.

Bon-Ton Stores Inc (BONT) < (BONT) is currently trading at $2.79 + 0.39 (16.25%) on 899,227 shares traded. Bon-Ton Stores Inc (BONT) < is -62.35% year-to-date, and -66.51% over the last 12 months.

Bon-Ton Stores Inc is a department store operator offering an assortment of brand-name fashion apparel and accessories for women, men and children as well as cosmetics, home furnishings and other goods.

Imprimis Pharmaceuticals Inc. (IMMY) < (IMMY) is currently trading at $7.36 + 1.00 (15.72%) on 147,140 shares traded. Imprimis Pharmaceuticals Inc. (IMMY) < is -1.87% year-to-date, and -11.33% over the last 12 months.

Imprimis Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing proprietary compounded drug therapies.

Bio Blast Pharma Ltd. (ORPN) < (ORPN) is currently trading at $5.24 + 0.71 (15.67%) on 42,796 shares traded. Bio Blast Pharma Ltd. (ORPN) < is -18.00% year-to-date, and -11.93% over the last 12 months.

Bio Blast Pharma Ltd is a development-stage biopharmaceutical company. It is engaged in the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.